These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27983866)

  • 1. Therapeutic Implications of Epigenetic Signaling in Breast Cancer.
    Oh TG; Wang SM; Muscat GE
    Endocrinology; 2017 Mar; 158(3):431-447. PubMed ID: 27983866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of histone modifications and variants in regulating gene expression in breast cancer.
    Dalvai M; Bystricky K
    J Mammary Gland Biol Neoplasia; 2010 Mar; 15(1):19-33. PubMed ID: 20131086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and Therapeutic Implications of Histone Epigenetic Modulators in Breast Cancer.
    Walsh L; Gallagher WM; O'Connor DP; Ní Chonghaile T
    Expert Rev Mol Diagn; 2016; 16(5):541-51. PubMed ID: 26895288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic targets and drug discovery Part 2: Histone demethylation and DNA methylation.
    Liu K; Liu Y; Lau JL; Min J
    Pharmacol Ther; 2015 Jul; 151():121-40. PubMed ID: 25857453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone modification therapy of cancer.
    Biancotto C; Frigè G; Minucci S
    Adv Genet; 2010; 70():341-86. PubMed ID: 20920755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic arginine methylation in breast cancer: emerging therapeutic strategies.
    Wang SM; Dowhan DH; Muscat GEO
    J Mol Endocrinol; 2019 Apr; 62(3):R223-R237. PubMed ID: 30620710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging epigenetic targets and therapies in cancer medicine.
    Popovic R; Licht JD
    Cancer Discov; 2012 May; 2(5):405-13. PubMed ID: 22588878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inactive X chromosome is epigenetically unstable and transcriptionally labile in breast cancer.
    Chaligné R; Popova T; Mendoza-Parra MA; Saleem MA; Gentien D; Ban K; Piolot T; Leroy O; Mariani O; Gronemeyer H; Vincent-Salomon A; Stern MH; Heard E
    Genome Res; 2015 Apr; 25(4):488-503. PubMed ID: 25653311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead.
    Mai A; Altucci L
    Int J Biochem Cell Biol; 2009 Jan; 41(1):199-213. PubMed ID: 18790076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic cancer therapy: Proof of concept and remaining challenges.
    Mund C; Lyko F
    Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative epigenomics of human and mouse mammary tumors.
    Demircan B; Dyer LM; Gerace M; Lobenhofer EK; Robertson KD; Brown KD
    Genes Chromosomes Cancer; 2009 Jan; 48(1):83-97. PubMed ID: 18836996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting epigenetic enzymes for autism treatment.
    Yan Z
    Trends Pharmacol Sci; 2024 Sep; 45(9):764-767. PubMed ID: 39034229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for compounds that modulate epigenetic regulation of the transcriptome: an overview.
    Eglen RM; Reisine T
    J Biomol Screen; 2011 Dec; 16(10):1137-52. PubMed ID: 22002420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
    Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
    Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and epigenetic aspects of breast cancer progression and therapy.
    Byler S; Goldgar S; Heerboth S; Leary M; Housman G; Moulton K; Sarkar S
    Anticancer Res; 2014 Mar; 34(3):1071-7. PubMed ID: 24596345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of adipogenesis by histone-modifying enzymes.
    Macchia PE; Nettore IC; Franchini F; Santana-Viera L; Ungaro P
    Epigenomics; 2021 Feb; 13(3):235-251. PubMed ID: 33502245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenomes as therapeutic targets.
    Hamm CA; Costa FF
    Pharmacol Ther; 2015 Jul; 151():72-86. PubMed ID: 25797698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic pathway targets for the treatment of disease: accelerating progress in the development of pharmacological tools: IUPHAR Review 11.
    Tough DF; Lewis HD; Rioja I; Lindon MJ; Prinjha RK
    Br J Pharmacol; 2014 Nov; 171(22):4981-5010. PubMed ID: 25060293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of Breast Cancer Pathogenesis by Histone Methylation and the Hairless Histone Demethylase.
    Trager MH; Sah B; Chen Z; Liu L
    Endocrinology; 2021 Aug; 162(8):. PubMed ID: 33928351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.